Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...
An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...
Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...
Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...
This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...
As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are ...
GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying ...
People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...
In June, Novo ended a partnership with Hims & Hers that provided access to Wegovy through the pharma's Novocare Pharmacy because Hims & Hers was trying to skirt legal restrictions on compounding ...
Somehow, it’s becoming even harder to get a GLP-1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback